002693 双成药业
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)-8.359-10.3031.811-4.170-10.260
总资产报酬率 ROA (%)-4.649-5.9201.021-2.307-5.739
投入资产回报率 ROIC (%)-5.661-7.2671.278-2.919-7.392

边际利润分析
销售毛利率 (%)59.95068.27267.86774.58977.664
营业利润率 (%)-40.431-31.007-3.280-12.033-29.229
息税前利润/营业总收入 (%)-35.271-26.9130.832-9.515-25.292
净利润/营业总收入 (%)-40.642-30.508-3.092-12.741-29.672

收益指标分析
经营活动净收益/利润总额(%)104.23057.871612.935140.51489.108
价值变动净收益/利润总额(%)-0.83150.845-52.175-10.200-3.614
营业外收支净额/利润总额(%)0.064-0.255-1.4704.5080.032

偿债能力分析
流动比率 (X)0.9960.9660.7901.5261.526
速动比率 (X)0.4880.4350.5851.0171.118
资产负债率 (%)43.45135.55636.23233.6790.341
带息债务/全部投入资本 (%)35.05325.94329.67325.67530.490
股东权益/带息债务 (%)180.534279.148232.168282.225222.138
股东权益/负债合计 (%)121.100165.085155.585167.422159.334
利息保障倍数 (X)-6.802-6.7040.205-3.083-6.408

营运能力分析
应收账款周转天数 (天)26.90831.35730.81924.17738.827
存货周转天数 (天)412.634335.973245.989238.927300.371